The Nifty opened at 14219.15 with a gap down of 77 points. Prices have recorded its intraday low at 14151.40 within the first 5 minutes of trading and then started an upside move. Prices have seen an intraday rally of more than 200 points to record its intraday high at 14424.75. The index finally closed at 14406.15 with a gain of 109.75 points. The Banks and Financials have performed well while FMCG was the biggest laggard.
The Nifty continued recording wide range days. The index opened with a gap down. The gap quickly filled by the prices and prices have moved further on the upside. The markets became total random as we are seeing one day up and one day down move. Short term support is visible around 14200 while resistance is around 14700.
Bank Nifty opened at 30763.50 with a gap down of 311 points. Prices have recorded its intraday low at 30555.25 and then started moving upside. The rally continued for the whole day and prices have finally closed at 31782. PSU and Private banks both have seen a rally and closed higher by 0.75% and 1.79% respectively. Within the index, ICICI Bank contributed highest while Indusind Bank the lowest. Back to Back trend day in the Bank Nifty are recorded. Last trading day was a down trending while yesterday was a trend day on the upside.
Support is visible around 30500 while resistance at 32500.
Trade AnyTime AnyWhere With Elite Empower Mobile App
|KOTAK BANK||1736.05||BUY||The stock has given a breakout from a narrow trading range. The stock can be bought at CMP with a stop at 1720 and for the target 1760.|
|APOLLOHOSP||3228.95||SELL||The stock has given a breakdown from a narrow trading range. The stock can be sold at CMP with a stop at 3260 and for the target 3180.|
Get All Your Mutual Fund Portfolio Retuns on Your Mobile by Elite Kuber App
|STOCK OPTION||Strike Price||Buy/Sell||CMP||Initiation||Stop Loss||Target||Remarks|
|IGL||510 CE||BUY||10.80||CMP||6||17||OI increase|
|Long Buildup||Short Buildup|
|Stocks||Price||Price%||OI %||OI||Stocks||Price||Price%||OI %||OI|
|NAVINFLUOR.21.04 Apr||3229||7.14||17.25||331875||GUJGASLTD.21.04 Apr||530.95||-2.11||30.85||1140000|
|WIPRO.21.04 Apr||486.2||3.49||13.14||44320000||ULTRACEMCO.21.04 Apr||6117||-1.68||17.42||2441000|
|BAJAJFINSV.21.04 Apr||9867.05||0.41||12.59||717500||ESCORTS.21.04 Apr||1174.5||-3.03||10.05||2071300|
|BANKNIFTY.21.04 Apr||31725.6||1.94||11.98||1847375||BATAINDIA.21.04 Apr||1297||-0.1||6.95||1768800|
|M&MFIN.21.04 Apr||176.75||3.42||11.06||17076000||AARTIIND.21.04 Apr||1418||-1.05||6.91||407575|
|Short Covering||Long Unwinding|
|Stocks||Price||Price%||OI%||OI||Stocks||Price||Price %||OI %||OI|
|FINNIFTYW.21.04 Apr||15239.75||1.97||-86.78||1920||NAM-INDIA.21.04 Apr||326.25||-0.61||-4.12||1897600|
|ADANIPORTS.21.04 Apr||737||2.16||-19.92||55377500||SHREECEM.21.04 Apr||28628.3||-2.61||-3.42||176300|
|GRASIM.21.04 Apr||1306.35||0.98||-9.94||14517900||MPHASIS.21.04 Apr||1643.65||-0.87||-3.23||623675|
|TORNTPOWER.21.04 Apr||384.6||1.53||-6.95||2049000||GRANULES.21.04 Apr||333.6||-0.28||-2.91||5995400|
|ADANIENT.21.04 Apr||1158.9||1.46||-4.15||15856000||PFIZER.21.04 Apr||5235.35||-4.97||-2.88||240250|
Get Stock Market Recommendation By Our Research Analysts
TOP DELIVERY PERCENTAGE
|Stocks||Price||%Chg||Total Qty||Delivery||Del %||% Change|
|Icici Lombard General In||1380.05||-1.35||443394||696667||75.02||Nifty Bank||31782.6||2.15||83460|
|Hdfc Ltd.||2479.7||2.64||4514740||4822407||65.47||Nifty Media||1506.55||1.84||83460|
|Hindustan Unilever Ltd||2349.4||-2||1721265||947816||59.63||Nifty Metal||4460.9||1.74||83460|
|Godrej Cons Products Ltd||704.1||-2.97||1362900||666225||59.54||Nifty Realty||305.15||1.29||83460|
|Reliance Industries Ltd||1906.4||0.28||6687573||4616077||58.14||Nifty 50||14406.15||0.77||83460|
|Pidilite Industries Ltd||1785.8||0.72||569960||241863||57.13||Nifty Energy||17370.95||0.17||83460|
|Dabur India Ltd.||566.15||-0.5||2545878||1320920||56.9||Nifty Auto||9644.55||0.14||83460|
|Tata Consultancy Serv Lt||3118.8||-0.82||1988980||1747537||55.62||Nifty it||25826.7||-0.2||83460|
|Hdfc Bank Ltd.||1422.5||2.24||19242656||6447436||55.61||Nifty Pharma||13378.95||-0.36||83460|
|Kotak Mahindra Bank Limi||1736.05||2.26||3590444||1837843||55.41||Nifty Fmcg||34043.05||-0.74||83460|
UPCOMING ECONOMIC DATA
|INR: Deposit Growth on 23th April, 2021
INR: Bank Loan Growth on 23nd April, 2021
|•USD : New Home Sales (Mar) on 23rd April, 2021
•USD: Core Durable Goods Orders (MoM) (Mar) on 26th April, 2021
|•L&T on Thursday said its construction arm has bagged up to Rs 2,500 crore order from Oilfields Supply Company Saudi to design and build an oil and gas supply base. The company did not provide value of the contracts but said the orders fall under “significant” category which ranges between Rs 1,000 crore and Rs 2,500 crore as per its classification of contracts.
•Sunteck Realty Ltd on Wednesday reported 16 per cent decline in its sales bookings at Rs 1,022 crore during the last fiscal year. The company had clocked sales bookings of Rs 1,221 crore in the previous year. Sunteck achieved lower sales bookings in the first six months of the 2020-21 at Rs 301 crore. The second half of last fiscal contributed Rs 720 crore to the overall sales bookings number.
•S&P Global Ratings on Thursday said the Indian economy is projected to grow at 11 per cent in the current fiscal, but flagged the “substantial” impact of broader lockdowns on the economy. In its report on Asia-Pacific Financial Institutions, S&P said the control of COVID-19 remains a key risk for the economy. New infections have spiked in recent weeks and the country is in the middle of a second pandemic wave.
•Pharma company Pfizer has offered to supply its messenger RNA (mRNA) vaccine to the Indian government at a “not-for-profit” price as part of its strategy of adopting a distinct pricing structure for different countries.
Source: Economic Times, Indian Express ,Business Today, Livemint, Business Standard, Bloomberg Quint
|Company Name||Purpose||Ex-Date||Company Name||Purpose||Ex-Date|
|ADROITINFO||Reduction of Capital||23-Apr-21||MEDINOV||Audited Results||23-Apr-21|
|ANMOL||General;Preferential Issue of shares||23-Apr-21||ORIENTHOT||Audited Results;Final Dividend||23-Apr-21|
|BIRLAMONEY||Audited Results;Quarterly Results||23-Apr-21||PRANAVSP||Audited Results||23-Apr-21|
|BOMBWIR||Audited Results||23-Apr-21||RADIXIND||Audited Results;Final Dividend||23-Apr-21|
|CONTROLPR||Audited Results;Dividend||23-Apr-21||SHIVACEM||Audited Results||23-Apr-21|
|GNA||Results;Dividend;Special Dividend||23-Apr-21||SMRUTHIORG||Audited Results;Dividend||23-Apr-21|
|HCLTECH||Audited Results;Interim Dividend||23-Apr-21||WENDT||Audited Results;Final Dividend||23-Apr-21|
|ICSL||Audited Results;General||23-Apr-21||AVANTEL||A.G.M.;Results;Final Dividend||24-Apr-21|
|M&MFIN||Audited Results;Dividend||23-Apr-21||DHAMPURSUG||Audited Results;General||24-Apr-21|
|Company Name||Ex-Date||Purpose||Company Name||Ex-Date||Purpose|
|ELANTAS||26-Apr-21||Dividend – Rs. – 5.00||ARCHIDPLY||29-Apr-21||E.G.M.|
|EASEMYTRIP||27-Apr-21||Interim Dividend – Rs. – 2.00||HCLTECH||29-Apr-21||Interim Dividend|
|WAA||27-Apr-21||Bonus issue 1:1||ISHANCH||29-Apr-21||Interim Dividend – Rs. – 1.2500|
|ZUARIGLOB||27-Apr-21||Interim Dividend – Rs. – 1.00||NESTLEIND||29-Apr-21||Final Dividend – Rs. – 65.00|
|ADL||29-Apr-21||E.G.M.||NESTLEIND||29-Apr-21||Interim Dividend – Rs. – 25.00|
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, firstname.lastname@example.org
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.Company-Specific Disclosures Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in , or e-mailing email@example.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail firstname.lastname@example.org.Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person. Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, advisory board member or employee of any company in the analyst’s area of coverage. Country Specific Disclosures India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL Advisory discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
a) EWL Advisory or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL Advisory or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL Advisory or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL Advisory or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL Advisory or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL Advisory or its associates have not received any compensation for products or services other than investment banking
or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL Advisory or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL Advisory
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL Advisory or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL Advisory has never been engaged in market making activity for the subject company;
(6) EWL Advisory shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.